Thalidomide-O-C3-acid, 100mg

(2-Bromoethyl)dimethylamine hydrobromide, 95.0%, 1g

5-Amino-1-[2-nitro-4-(trifluoromethyl)phenyl]-1H-pyrazole-4-carbonitrile, 1g

(2E)-1,3-bis(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

2-Bromo-6-ethylpyridine, 95.0%, 5g

7-Fluoro-3-hydroxy-3-phenylindolin-2-one, 98%, 250mg

(2R,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 98%, 250mg

1,1,1,3,5,7,7,7-Octamethyltetrasiloxane>95.0%(GC)25g

(R)-1-[3-(Trifluoromethyl)phenyl]ethylaminehydrochloride, 95.0%, 10g

5-Bromo-2-methoxy-6-methyl pyridine, 97.0%, 25g

(4-Methyl-piperazin-1-yl)-(S)-pyrrolidin-2-yl-methanone, 98%, 1g

(3S,4S)-3-METHYL-2-OXA-8-AZASPIRO[4.5]DECAN-4-AMINE 2HCL, 95.0%, 25g

?-Hydroxyglutaric acid disodium, 10mg